Psychological distress among patients with lymphoma: the association with personality and coping strategies

Arts, Lindy Paulina Johanna; Oerlemans, Simone; Schoormans, Dounya; Sanders, Arnate L.T.M.; Stevens, Wendy B C; Posthuma, Eduardus F M; Tick, Lidwine W.; Poll‐Franse, Lonneke V. van de

doi:10.1097/or9.0000000000000041

Cited by 3 publications

(4 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the age of patients included in the study did not correlate statistically significant with GWB score. The same conclusion was formulated following the study of psycho-emotional distress in 456 patients with lymphoma in the Netherlands 22 . The authors concluded that younger patients experienced more psychological distress.…”

Section: Discussionmentioning

confidence: 67%

The Global Well-Being of Patients With Non-Hodgkin Lymphomas

Buruiana¹,

Mazur-Nicorici²,

Robu³

et al. 2023

Arch Balk Med Union

View full text Add to dashboard Cite

Le bien-être global des patients atteints de lymphomes non hodgkiniensIntroduction. Le lymphome non hodgkinien (LNH) est une tumeur lymphoïde ayant un impact sur la santé physique, psychologique, le spirituel bien-être, l'intégration sociale, la relation vie-maladie étant ainsi multidimensionnelle. L'objectif de l'étude était d'évaluer le bien-être global des patients atteints de LNH. Materiel et méthodes. L'étude descriptive de 116 patients adultes (65 femmes, 51 hommes) atteints de LNH a été menée. L'entretien individuel a été réalisé suite à une enquête de bien-être épidémiologique, clinique et psychologique (GWB). Résultats. La moyenne du score GWB était plus faible chez les patients du groupe d'âge 18-40 ans (score moyen 43,75), était plus élevée chez les hommes (62,2, détresse modérée), ce qui exprime moins de stress psycho-émotionnel par rapport aux femmes (54,5, sévère détresse). Les patients atteints d'un LNH agressif ont rapporté un score GWB significativement plus faible (p = 0,003). La maladie extra ganglionnaire (p = 0,15)

show abstract

Section: Discussionmentioning

confidence: 67%

The Global Well-Being of Patients With Non-Hodgkin Lymphomas

Buruiana¹,

Mazur-Nicorici²,

Robu³

et al. 2023

Arch Balk Med Union

View full text Add to dashboard Cite

show abstract

“…focused on modifiable lifestyle factors or coping mechanisms). 27,[54][55][56] Additionally, it might also lead to improved symptom monitoring and better expectation management, which can help patients in making informed treatment decisions with their haematologist. [25][26][27] In conclusion, up to 10 years after diagnosis, patients with iNHL report a substantially lower HRQoL compared with an age-and sex-matched normative population.…”

Section: Discussionmentioning

confidence: 99%

“…This will not only improve early detection but will also enable us to develop tailored supportive care and treatment strategies for those in need (e.g. focused on modifiable lifestyle factors or coping mechanisms) 27,54–56 . Additionally, it might also lead to improved symptom monitoring and better expectation management, which can help patients in making informed treatment decisions with their haematologist 25–27 …”

Section: Discussionmentioning

confidence: 99%

Persistent symptoms of fatigue, neuropathy and role‐functioning impairment among indolent non‐Hodgkin lymphoma survivors: A longitudinal PROFILES registry study

et al. 2022

Self Cite

View full text Add to dashboard Cite

Summary Little is known about the long‐term health‐related quality of life (HRQoL) and persistence of symptoms among patients with indolent non‐Hodgkin lymphoma (iNHL). This large population‐based longitudinal study therefore investigated the long‐term HRQoL and persistence of symptoms and identified associated sociodemographic, clinical and psychological factors. Patients diagnosed between 1999 and 2014 and four or more months after diagnosis were invited to participate in a longitudinal survey. Sociodemographic and clinical data were obtained from the Netherlands Cancer Registry. The EORTC QLQ‐C30 and CLL‐16 were completed by 669 patients (74% response rate). Patients completed on average four questionnaires. Primary treatment was active surveillance (52%), systemic therapy (31%) or radiotherapy (13%). Respectively, 36% reported persistent fatigue, 33% persistent neuropathy and 25% persistent role‐functioning impairment. This was 2–3 times higher than in the age‐ and sex‐matched normative population. Up to 10 years after diagnosis, scores remained relatively stable without clinically relevant changes. Comorbidities, psychological distress, shorter time since diagnosis, systemic therapy, younger age, education level and having no partner were associated with worse outcomes (all ps < 0.05). Up to a third of patients with iNHL experience long‐term persistent symptoms which do not improve over time. Early recognition of symptoms will help in providing tailored supportive care for those in need.

show abstract

“…Psychological distress is usually detected by measuring both anxiety and depression, and a high value of anxiety and/or depression is defined as high psychological distress ( Loge et al, 1997 ; Aksnes et al, 2007 ; ACTION Study Group, 2017 ; Arts et al, 2018 , 2021 ). Lack of detection of anxiety and depression has been shown to significantly affect the quality of life (QoL) and even increase mortality ( Cuijpers and Smit, 2002 ; Pinquart and Duberstein, 2010 ; Mols et al, 2013 ).…”

Section: Introductionmentioning

confidence: 99%

Cancer-Related Psychological Distress in Lymphoma Survivor: An Italian Cross-Sectional Study

Agostinelli¹,

Muzzatti²,

Serpentini³

et al. 2022

Front. Psychol.

View full text Add to dashboard Cite

Cancer is becoming a chronic disease, and the number of cancer survivors continues to increase. Lymphoma survivors are also increasing in numbers, and anxiety and depression are among the consequences they face. This study aimed to explore psychological distress in a sample of 212 lymphoma survivors. Information through a socio-demographic form and the compilation of questionnaires to assess anxiety, depression, quality of life, and the impact of cancer on lymphoma survivors was collected and analyzed. In the sample examined, 17% of lymphoma survivors were anxiety caseness, and 12.3% were depression caseness, and of these, 8% presented with concomitant anxiety depression. This study identified some variables associated with psychological distress in lymphoma survivors: female sex; living as a couple; a diagnosis of Hodgkin lymphoma; systematic treatment and/or radiotherapy; sleep disorders; no regular physical activity; and present or past use of psychiatric drugs. Our cross-sectional study results suggest that some of the variables investigated may be useful in identifying lymphoma survivors who are more likely to report psychological distress. It is important to monitor psychological distress along the entire trajectory of survivorship in order to identify early the presence of anxiety and depression and to provide timely psychological support.

show abstract

Psychological distress among patients with lymphoma: the association with personality and coping strategies

Cited by 3 publications

References 39 publications

The Global Well-Being of Patients With Non-Hodgkin Lymphomas

The Global Well-Being of Patients With Non-Hodgkin Lymphomas

Persistent symptoms of fatigue, neuropathy and role‐functioning impairment among indolent non‐Hodgkin lymphoma survivors: A longitudinal PROFILES registry study

Cancer-Related Psychological Distress in Lymphoma Survivor: An Italian Cross-Sectional Study

Contact Info

Product

Resources

About